PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

Detalles Bibliográficos
Autores principales: Tsykunova, G., Holme, P. A., Thi Thyuet Tran, H., Tvedt, T. H. A., Munthe, L., Michel, M., Frederiksen, H., Bussel, J., Kuter, D., Ghanima, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429352/
http://dx.doi.org/10.1097/01.HS9.0000852076.33574.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429352/
http://dx.doi.org/10.1097/01.HS9.0000852076.33574.89

Ejemplares similares